Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label,single-arm,multicentre, phase 2 trial |
| |
| Affiliation: | 1. Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU de Lille, Université de Lille, Lille, France;2. Department of Hematology and INSERM U1245, Centre Henri Becquerel and Rouen University, Rouen, France;3. Centre for Haematology, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, Hammersmith Hospital & Imperial College Healthcare NHS Trust, London, UK;4. Department of Hematology, Beatson West of Scotland Cancer Centre, Glasgow, UK;5. Division of Hematology and Oncology, University of Michigan, Ann Arbor, MI, USA;6. Division of Hematology, Jewish General Hospital, Montreal, QC, Canada;7. Department of Oncology, McGill University, Montreal, QC, Canada;8. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;9. Department of Clinical Haematology, Barwon Health, University Hospital Geelong, Geelong, VIC, Australia;10. Hematology Department, Gustave Roussy, Villejuif, France;11. Hematology Institute, Hematologie Clinique, University Hospital School of Medicine, Caen, France;12. Department of Clinical Haematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia;13. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia;14. Department of Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland;15. Department of Hematology and Bone Marrow Transplantation, Poznań University of Medical Sciences, Poznań, Poland;p. Haematology Department, Monash University, Melbourne, VIC, Australia;q. Department of Medical Oncology, University of Manchester, Manchester, UK;r. NIHR Manchester Clinical Research Facility, Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK;s. Department of Hematology, Institut Bergonié, Bordeaux, France;t. Clinical Development, Epizyme, Cambridge, MA, USA;u. Department of Hematology, Lyon-Sud Hospital, University of Lyon, Pierre-Bénite, France |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
